by Pete Celano | Jul 3, 2026 | Blog
This new Clinical Gastroenterology and Hepatology (CGH) study is one of the strongest observational studies to date examining coffee and liver health because it combines long-term clinical outcomes with liver MRI imaging and blood proteomics, providing biologic...
by David Sires | Jul 1, 2026 | Blog
The PharmaVoice article titled “3 late-stage MASH drugs that could rival Rezdiffra” highlights the next wave of MASH therapies expected to compete with Madrigal’s Rezdiffra (resmetirom), emphasizing that the future of MASH treatment will likely...
by Brandon Tudor | Jun 29, 2026 | Blog
Here are the key takeaways from the HCPLive article, “Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework,” by Dr. Zobair Younossi (published June 23, 2026). 1. MASLD treatment is entering a new era The article argues...
by Brandon Tudor | Jun 27, 2026 | Blog
It’s straightforward.
by David Sires | Jun 25, 2026 | Blog
This LinkedIn post highlights a major milestone by the Beth Israel Deaconess Medical Center (BIDMC) Transplant Institute.”The robotic approach brought a new dimension to an already complex operation led by transplant surgeons Drs. Martin Dib and Vincenzo Villani...
by Brandon Tudor | Jun 23, 2026 | Blog
Summary: Microplastics May Worsen Fatty Liver Disease, New Study Suggests Researchers at the University of Oklahoma have found that microplastics may significantly worsen fatty liver disease, especially when combined with a high-fat, high-cholesterol diet. The...
